By Feroz Jameel, Susan Hershenson
A real-world advisor to the construction and production of biopharmaceuticals
While a lot has been written in regards to the technology of biopharmaceuticals, there's a want for useful, up to date info on key concerns in any respect phases of constructing and production commercially possible biopharmaceutical drug items. This e-book is helping fill the distance within the box, reading all components of biopharmaceuticals production, from improvement and formula to creation and packaging.
Written through a bunch of specialists from and academia, the ebook makes a speciality of real-world tools for preserving product integrity during the commercialization procedure, sincerely explaining the basics and crucial pathways for all improvement phases. assurance contains:
-
Research and early improvement phase?appropriate techniques for making sure product stability
-
Development of commercially conceivable formulations for liquid and lyophilized dosage forms
-
Optimal garage, packaging, and transport methods
-
Case reviews when it comes to healing monoclonal antibodies, recombinant proteins, and plasma fractions
-
Useful research of winning and failed products
Formulation and method improvement concepts for production Biopharma-ceuticals is a necessary source for scientists and engineers within the pharmaceutical and biotech industries, for presidency and regulatory enterprises, and for someone with an curiosity within the most up-to-date advancements within the field.Content:
Chapter 1 The constitution of organic Therapeutics (pages 1–40): Sheryl Martin?Moe, Tim Osslund, Y. John Wang, Tahir Mahmood, Rohini Deshpande and Susan Hershenson
Chapter 2 Chemical Instability in Peptide and Protein prescription drugs (pages 41–67): Elizabeth M. Topp, Lei Zhang, Hong Zhao, Robert W. Payne, Gabriel J. Evans and Mark Cornell Manning
Chapter three actual balance of Protein prescribed drugs (pages 69–104): Byeong S. Chang and Bernice Yeung
Chapter four Immunogenicity of healing Proteins (pages 105–117): Steven J. Swanson
Chapter five Preformulation learn: Assessing Protein resolution habit in the course of Early improvement (pages 119–146): Bernardo Perez?Ramirez, Nicholas Guziewicz and Robert Simler
Chapter 6 formula improvement of part 1–2 Biopharmaceuticals: a good and well timed method (pages 147–159): Nicholas W. Warne
Chapter 7 Late?Stage formula improvement and Characterization of Biopharmaceuticals (pages 161–171): Adeola O. Grillo
Chapter eight An Empirical part Diagram–High?Throughput Screening method of the Characterization and formula of Biopharmaceuticals (pages 173–205): Sangeeta B. Joshi, Akhilesh Bhambhani, Yuhong Zeng and C. Russell Middaugh
Chapter nine Fluorescence and Phosphorescence ways to Probe Protein constitution and balance in Ice: The Case of Azurin (pages 207–229): Giovanni B. Strambini
Chapter 10 functions of Sedimentation pace Analytical Ultracentrifugation (pages 231–251): Tom Laue
Chapter eleven box move Fractionation with Multiangle mild Scattering for Measuring Particle dimension Distributions of Virus?Like debris (pages 253–268): Joyce A. Sweeney and Christopher Hamm
Chapter 12 Light?Scattering thoughts and their software to formula and Aggregation issues (pages 269–305): Michael Larkin and Philip Wyatt
Chapter thirteen powerful methods to formula improvement of Biopharmaceuticals (pages 307–328): Rajiv Nayar and Mitra Mosharraf
Chapter 14 Prediction of Aggregation Propensity from basic series details (pages 329–347): Mark Cornell Manning, Gabriel J. Evans, Cody M. Van Pelt and Robert W. Payne
Chapter 15 High?Concentration Antibody Formulations (pages 349–381): Steven J. Shire, Jun Liu, Wolfgang Friess, Susanne Jorg and Hanns?Christian Mahler
Chapter sixteen improvement of Formulations for healing Monoclonal Antibodies and Fc Fusion Proteins (pages 383–427): Sampathkumar Krishnan, Monica M. Pallitto and Margaret S. Ricci
Chapter 17 Reversible Self?Association of Pharmaceutical Proteins: Characterization and Case stories (pages 429–455): Vikas ok. Sharma, Harminder Bajaj and Devendra S. Kalonia
Chapter 18 layout of a formula for Freeze Drying (pages 457–492): Feroz Jameel and Mike J. Pikal
Chapter 19 Protein Conformation and Reactivity in Amorphous Solids (pages 493–506): Lei Zhang, Sandipan Sinha and Elizabeth M. Topp
Chapter 20 The effect of Buffer on Solid?State homes and balance of Freeze?Dried Dosage kinds (pages 507–519): Evgenyi Y. Shalaev and Larry A. Gatlin
Chapter 21 Stabilization of Lyophilized prescribed drugs by means of regulate of Molecular Mobility: influence of Thermal background (pages 521–548): Suman Luthra and Michael J. Pikal
Chapter 22 Structural research of Proteins in Dried Matrices (pages 549–563): Andrea Hawe, Sandipan Sinha, Wolfgang Friess and Wim Jiskoot
Chapter 23 The influence of formula and Drying procedures at the features and function of Biopharmaceutical Powders (pages 565–585): Vu L. Truong and Ahmad M. Abdul?Fattah
Chapter 24 production basics for Biopharmaceuticals (pages 587–604): Maninder Hora
Chapter 25 Protein balance in the course of Bioprocessing (pages 605–624): Mark Cornell Manning, Gabriel J. Evans and Robert W. Payne
Chapter 26 Freezing and Thawing of Protein ideas (pages 625–675): Satish okay. Singh and Sandeep Nema
Chapter 27 techniques for Bulk garage and cargo of Proteins (pages 677–704): Feroz Jameel, Chakradhar Padala and Theodore W. Randolph
Chapter 28 Drying technique tools for Biopharmaceutical items: an summary (pages 705–738): Ahmad M. Abdul?Fattah and Vu L. Truong
Chapter 29 Spray Drying of Biopharmaceuticals and Vaccines (pages 739–761): Jim Searles and Govindan Mohan
Chapter 30 improvement and Optimization of the Freeze?Drying methods (pages 763–796): Feroz Jameel and Jim Searles
Chapter 31 concerns for profitable Lyophilization technique Scale?Up, know-how move, and regimen construction (pages 797–826): Samir U. Sane and Chung C. Hsu
Chapter 32 technique Robustness in Freeze Drying of Biopharmaceuticals (pages 827–837): D. Q. Wang, D. MacLean and X. Ma
Chapter 33 Filling methods and applied sciences for Liquid Biopharmaceuticals (pages 839–856): Ananth Sethuraman, Xiaogang Pan, Bhavya Mehta and Vinay Radhakrishnan
Chapter 34 Leachables and Extractables (pages 857–880): Jim Castner, Pedro Benites and Michael Bresnick
Chapter 35 basic box and Closure choice for Biopharmaceuticals (pages 881–896): Olivia Henderson
Chapter 36 Prefilled Syringes for Biopharmaceuticals (pages 897–916): Robert Swift
Chapter 37 impression of producing approaches on Drug Product balance and caliber (pages 917–940): Nitin Rathore, Rahul S. Rajan and Erwin Freund
Read Online or Download Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals PDF
Similar manufacturing books
Soldering in Electronics Assembly
Managers, engineers and technicians will use this publication in the course of commercial development of electronics assemblies, while scholars can use the ebook to get a seize of the range of equipment to be had, including a dialogue of technical issues. It contains over two hundred illustrations, together with a photographic consultant to defects, and comprises many line drawings, tables and circulation charts to demonstrate the topic of electronics meeting.
Advanced manufacturing: an ICT and systems perspective
Production performs an important position in eu financial system and society, and is anticipated to proceed as an incredible generator of wealth within the foreseeable destiny. A aggressive production is key for the prosperity of Europe, specially within the face of increasing deindustrialisation. This booklet offers a vast imaginative and prescient of the way forward for production, analysed from a system-management perspective and with a distinct specialise in ICT-related issues.
This insightful reference demonstrates a approach of dimension, inspection, gaging, geometric tolerancing, and fixturing of goods in complete compliance with the yankee nationwide criteria Institute (ANSI), the yankee Society of Mechanical Engineers (ASME), and the foreign association for Standardization (ISO) licensed criteria.
Synthetic Fibers: Machines and Equipment Manufacture, Properties
At the present time, nearly 20 million t/year of man-made fibers are produced, approximately forty five% of the realm fiber construction. even supposing the has grown speedily, formerly there was no English language textual content overlaying the layout of machines and kit for the construction of artificial fibers -- from uncooked fabrics to the ultimate product.
- Computer-aided Manufacturing and Women’s Employment: The Clothing Industry in Four EC Countries: For the Directorate-General Employment, Social Affairs and Education of the European Communities, June 1990
- Green Power, Materials and Manufacturing Technology and Applications II
- Engineering Metrology
- Reconfigurable Manufacturing Systems and Transformable Factories
- Career Ideas For Teens In Manufacturing
- Electrolytic In-Process Dressing (ELID) Technologies: Fundamentals and Applications
Extra info for Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals
Sample text
See the insert for color representation of this figure. candidates in this structural class have not been commercialized, a few have made it to the market. Platelet-derived growth factor (Regranex or becaplermin by OMJ in 1997) in carboxymethyl cellulose topical gel was approved for treatment of diabetic foot ulcers [16]. A second use of PDGF is in a calcium phosphate matrix used for the treatment of periodontal bone defects, (GEM 21S by Biomimetics in 2005). Other cases of growth factors incorporated into a matrix are bone morphogenic protein-7 (BMP-7) (OP-1 Putty by Stryker Biotech in 2001) as osteoinductive and conductive bone graft material, and BMP in an absorbable collagen sponge (dibotermin-α as INFUSE® bone graft device by Wyeth in 2004), which is indicated for spinal fusion procedures in skeletally mature patients with degenerative disk disease (all are mentioned in Ref.
More recent reports on camelid antibodies have revived interest in this class since, unlike mouse VH domains, camelid VhH domains are in general soluble and can be produced as stable in vitro targeting reagents for diagnostic platforms and nanosensors [109]. For therapeutic applications, humanization may be required to reduce immunogenicity. It may be desirable for some applications to design multivalent antibody fragments with greater functional avidity and slower dissociation rates for cell surface or multimeric antigens.
J. (2006), Potent antibody therapeutics by design, Nat. Rev. Immunol . 6: 343–357. 20. Baker, M. (2005), Upping the ante on antibodies, Nat. Biotechnol . 23: 1065–1072. 21. Itakura, K. et al. (1977), Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin, Science 198: 1056–1063. 22. Goeddel, D. V. et al. (1979), Expression in Escherichia coli of chemically synthesized genes for human insulin, Proc. Natl. Acad. Sci. USA 76: 106–110. 23. Goeddel, D. V. et al.